Bristol Myers Squibb engaged in Acceleron buyout talks but couldn’t justify the price: report

Bristol Myers Squibb engaged in Acceleron buyout talks but couldn’t justify the price: report
esagonowsky
Wed, 10/13/2021 – 09:10